The incidence of thyroid cancer has increased, mainly due to the incidental finding of low-risk papillary thyroid cancers (PTC). These malignancies grow slowly, and are unlikely to cause morbidity and mortality. New understanding about the prognosis of tumor features has led to reclassification of many tumors within the low-risk thyroid category, and to the development of a new one “very low-risk tumors.” Alternative less aggressive approaches to therapy are now available including active surveillance and minimally invasive interventions. In this narrative review, we have summarized the available evidence for the management of low-risk PTC.

Citations

Citations to this article as recorded by  

• Risk of malignancy in Thy3 thyroid nodules
  Emad Mofid Nassif Rezkallah, Ragai Sobhi Hanna, Wael Magdy Elsaify
  Endocrine Regulations.2024; 58(1): 19.     CrossRef
• Adequacy of clinical guideline recommendations for patients with low-risk cancer managed with monitoring: systematic review
  Kiana K. Collins, Claire Friedemann Smith, Tori Ford, Nia Roberts, Brian D. Nicholson, Jason L. Oke
  Journal of Clinical Epidemiology.2024; 169: 111280.     CrossRef
• Integrated metabolic and genetic analysis reveals distinct features of human differentiated thyroid cancer
  Eduardo Cararo Lopes, Akshada Sawant, Dirk Moore, Hua Ke, Fuqian Shi, Saurabh Laddha, Ying Chen, Anchal Sharma, Jake Naumann, Jessie Yanxiang Guo, Maria Gomez, Maria Ibrahim, Tracey L. Smith, Gregory M. Riedlinger, Edmund C. Lattime, Stanley Trooskin, Shr
  Clinical and Translational Medicine.2023;[Epub]     CrossRef
• Clinical management of low-risk papillary thyroid microcarcinoma
  Chie MASAKI, Kiminori SUGINO, Koichi ITO
  Minerva Endocrinology.2022;[Epub]     CrossRef
• The circ_FAM53B-miR-183-5p-CCDC6 axis modulates the malignant behaviors of papillary thyroid carcinoma cells
  Chong Zhang, Huxia Gu, Dingrong Liu, Fuyun Tong, Huijie Wei, Dan Zhou, Jing Fang, Xiaolu Dai, Haibo Tian
  Molecular and Cellular Biochemistry.2022; 477(11): 2627.     CrossRef
• An Appraisal and Update of Fluorodeoxyglucose and Non-Fluorodeoxyglucose-PET Tracers in Thyroid and Non–Thyroid Endocrine Neoplasms
  Aadil Adnan, Shobhana Raju, Rakesh Kumar, Sandip Basu
  PET Clinics.2022; 17(3): 343.     CrossRef
• A Narrative Review of Preventive Central Lymph Node Dissection in Patients With Papillary Thyroid Cancer - A Necessity or an Excess
  David D. Dolidze, Alexey V. Shabunin, Robert B. Mumladze, Arshak V. Vardanyan, Serghei D. Covantsev, Alexander M. Shulutko, Vasiliy I. Semikov, Khalid M. Isaev, Airazat M. Kazaryan
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Ethanol Ablation as a Treatment in a Low-Risk Follicular Thyroid Cancer: A Case Report
  Juan Pesantez, Carla Lituma, Carla Valencia, Jose Prieto, Marco Cazorla
  Cureus.2022;[Epub]     CrossRef
• The new T3b category has clinical significance? SEER‐based study
  Jingzhe Xiang, Zhihong Wang, Wei Sun, Hao Zhang
  Clinical Endocrinology.2021; 94(3): 449.     CrossRef
• Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter Study
  Xiao-Jing Cao, Juan Liu, Ya-Lin Zhu, Lu Qi, Geng Liu, Hong-Ling Wang, Zhong-Hua Wang, Ying Zhou, Jun-Feng He, Jian-Qin Guo, Li-Li Shi, Mei Jian, Aini Shataer, Guo-Zhen Yan, Zhen-Long Zhao, Ying Wei, Li-Li Peng, Yan Li, Ying Che, Shu-Rong Wang, Ming-An Yu
  The Journal of Clinical Endocrinology & Metabolism.2021; 106(2): e573.     CrossRef
• A Clinical Audit of Hemithyroidectomy for Differentiated Thyroid Cancer—Experience from a Tertiary Cancer Center
  Nithyanand Chidambaranathan, Shivakumar Thiagarajan, Nandini Menon, Adhara Chakraborthy, Richa Vaish, Devendra Chaukar
  Indian Journal of Surgery.2021; 83(6): 1444.     CrossRef
• Pros and cons of hemi‐thyroidectomy for low‐risk differentiated thyroid cancer
  Alexander J. Papachristos, Anthony Glover, Mark S. Sywak, Stan B. Sidhu
  ANZ Journal of Surgery.2021; 91(9): 1704.     CrossRef
• Lactate Dehydrogenase A as a Potential New Biomarker for Thyroid Cancer
  Eun Jeong Ban, Daham Kim, Jin Kyong Kim, Sang-Wook Kang, Jandee Lee, Jong Ju Jeong, Kee-Hyun Nam, Woong Youn Chung, Kunhong Kim
  Endocrinology and Metabolism.2021; 36(1): 96.     CrossRef
• Taraxasterol inhibits TGF-β1-induced epithelial-to-mesenchymal transition in papillary thyroid cancer cells through regulating the Wnt/β-catenin signaling
  J Zhu, X Li, S Zhang, J Liu, X Yao, Q Zhao, B Kou, P Han, X Wang, Y Bai, Z Zheng, C Xu
  Human & Experimental Toxicology.2021; 40(12_suppl): S87.     CrossRef
• Is Delayed Papillary Thyroid Cancer Surgery Associated with Higher Mortality Risk?
  Eddy P. Lincango Naranjo, Juan P. Brito
  Clinical Thyroidology.2021; 33(9): 400.     CrossRef
• MicroRNA-99a-3p/GRP94 axis affects metastatic progression of human papillary thyroid carcinoma by regulating ITGA2 expression and localization
  Yun Gao, Yi Pan, Tingting Wang, Ying Yao, Wenbo Yuan, Xue Zhu, Ke Wang
  Acta Biochimica et Biophysica Sinica.2021; 53(12): 1650.     CrossRef
• Microscopic Extrathyroidal Extension Results in Increased Rate of Tumor Recurrence and Is an Independent Predictor of Patient’s Outcome in Middle Eastern Papillary Thyroid Carcinoma
  Sandeep Kumar Parvathareddy, Abdul K. Siraj, Zeeshan Qadri, Felisa DeVera, Khawar Siddiqui, Saif S. Al-Sobhi, Fouad Al-Dayel, Khawla S. Al-Kuraya
  Frontiers in Oncology.2021;[Epub]     CrossRef
• New paradigms in the treatment of low-risk thyroid cancer
  Firas Baidoun, Anas M. Saad, Omar Abdel-Rahman
  Expert Review of Endocrinology & Metabolism.2020; 15(4): 251.     CrossRef
• The Impact of Transcription Factor Prospero Homeobox 1 on the Regulation of Thyroid Cancer Malignancy
  Magdalena Rudzińska, Barbara Czarnocka
  International Journal of Molecular Sciences.2020; 21(9): 3220.     CrossRef
• Modified risk stratification based on cervical lymph node metastases following lobectomy for papillary thyroid carcinoma
  Eyun Song, Jonghwa Ahn, Dong Eun Song, Won Woong Kim, Min Ji Jeon, Tae‐Yon Sung, Tae Yong Kim, Ki Wook Chung, Won Bae Kim, Young Kee Shong, Suck Joon Hong, Yu‐Mi Lee, Won Gu Kim
  Clinical Endocrinology.2020; 92(4): 358.     CrossRef
• Clinicopathological significance of the single nucleotide polymorphism, rs2853669 within the TERT promoter in papillary thyroid carcinoma
  Tatsuya Hirokawa, Yuu Arimasu, Tomohiro Chiba, Masachika Fujiwara, Hiroshi Kamma
  Pathology International.2020; 70(4): 217.     CrossRef
• Diagnostic accuracy and ability to reduce unnecessary FNAC: A comparison between four Thyroid Imaging Reporting Data System (TI-RADS) versions
  Lingsze Tan, Ying Sern Tan, Suzet Tan
  Clinical Imaging.2020; 65: 133.     CrossRef
• Amino Acid Transporters as Potential Therapeutic Targets in Thyroid Cancer
  Keisuke Enomoto, Muneki Hotomi
  Endocrinology and Metabolism.2020; 35(2): 227.     CrossRef
• FDG PET/CT versus somatostatin receptor PET/CT in TENIS syndrome: a systematic review and meta-analysis
  Felipe Alves Mourato, Maria Amorim Almeida, Ana Emília Teixeira Brito, Aline Lopes Garcia Leal, Paulo Almeida Filho, Elba Etchebehere
  Clinical and Translational Imaging.2020; 8(5): 365.     CrossRef
• Factors Associated with Health Behaviors in Thyroid Cancer Survivors
  Junghyun Yoon, Boyoung Park
  Journal of Cancer Prevention.2020; 25(3): 173.     CrossRef
• Patient-Derived Papillary Thyroid Cancer Organoids for Radioactive Iodine Refractory Screening
  Luc H.J. Sondorp, Vivian M.L. Ogundipe, Andries H. Groen, Wendy Kelder, Annelies Kemper, Thera P. Links, Robert P. Coppes, Schelto Kruijff
  Cancers.2020; 12(11): 3212.     CrossRef
• Hemithyroidectomy for Thyroid Cancer: A Review
  Noor Addasi, Abbey Fingeret, Whitney Goldner
  Medicina.2020; 56(11): 586.     CrossRef
• Clinical Outcomes after Early and Delayed Radioiodine Remnant Ablation in Patients with Low-Risk Papillary Thyroid Carcinoma: Propensity Score Matching Analysis
  Jonghwa Ahn, Meihua Jin, Eyun Song, Min Ji Jeon, Tae Yong Kim, Jin-Sook Ryu, Won Bae Kim, Young Kee Shong, Ji Min Han, Won Gu Kim
  Endocrinology and Metabolism.2020; 35(4): 830.     CrossRef
• Clinical Significance of Gross Invasion of Strap Muscles in Patients With 1- to 4-cm-Sized Papillary Thyroid Carcinoma Undergoing Lobectomy
  Eyun Song, Won Woong Kim, Min Ji Jeon, Tae-Yon Sung, Dong Eun Song, Tae Yong Kim, Ki Wook Chung, Won Bae Kim, Young Kee Shong, Suck Joon Hong, Yu-Mi Lee, Won Gu Kim
  Annals of Surgical Oncology.2019; 26(13): 4466.     CrossRef
• Lobectomy Is Feasible for 1–4 cm Papillary Thyroid Carcinomas: A 10-Year Propensity Score Matched-Pair Analysis on Recurrence
  Eyun Song, Minkyu Han, Hye-Seon Oh, Won Woong Kim, Min Ji Jeon, Yu-Mi Lee, Tae Yong Kim, Ki Wook Chung, Won Bae Kim, Young Kee Shong, Suck Joon Hong, Tae-Yon Sung, Won Gu Kim
  Thyroid.2019; 29(1): 64.     CrossRef
• Laser and radiofrequency ablations for benign and malignant thyroid tumors
  Giovanni Mauri, Nicolò Gennaro, Min Kyoung Lee, Jung Hwan Baek
  International Journal of Hyperthermia.2019; 36(2): 13.     CrossRef
• US-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: Efficacy and Safety in a Large Population
  Hyun Kyung Lim, Se Jin Cho, Jung Hwan Baek, Kang Dae Lee, Chang Woo Son, Jung Min Son, Seon Mi Baek
  Korean Journal of Radiology.2019; 20(12): 1653.     CrossRef
• Utility of Early Postoperative Unstimulated Thyroglobulin in Influencing Decision Making in Patients with Papillary Thyroid Carcinoma
  Alexandria D. McDow, Cynthia M. Shumway, Susan C. Pitt, David F. Schneider, Rebecca S. Sippel, Kristin L. Long
  Annals of Surgical Oncology.2019; 26(12): 4002.     CrossRef
• Extent of Surgery for Low-Risk Differentiated Thyroid Cancer
  Alexandria D. McDow, Susan C. Pitt
  Surgical Clinics of North America.2019; 99(4): 599.     CrossRef